Go Pro
→ Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown” (From Paradigm Press) (Ad)tc pixel Free FBIOP Stock Alerts

Fortress Biotech (FBIOP) Competitors

Fortress Biotech logo
$17.75 -0.15 (-0.84%)
Closing price 09/18/2026 03:58 PM Eastern
Extended Trading
$17.62 -0.13 (-0.73%)
As of 09/18/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

FBIOP vs. SXTPW, BFRIW, CINGW, CLVR, and CMRAW

Should you buy Fortress Biotech stock or one of its competitors? Fortress Biotech's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Biofrontera (BFRIW), Cingulate (CINGW), Clever Leaves (CLVR), and Comera Life Sciences (CMRAW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Fortress Biotech compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Fortress Biotech (NASDAQ:FBIOP) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, risk, earnings, profitability, dividends, valuation and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
Fortress Biotech N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.11MN/AN/AN/AN/A
Fortress Biotech$68.47MN/AN/AN/AN/A

In the previous week, 60 Degrees Pharmaceuticals and 60 Degrees Pharmaceuticals both had 1 articles in the media. Fortress Biotech's average media sentiment score of 0.55 beat 60 Degrees Pharmaceuticals' score of 0.00 indicating that Fortress Biotech is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
60 Degrees Pharmaceuticals
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Fortress Biotech
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Fortress Biotech beats 60 Degrees Pharmaceuticals on 2 of the 2 factors compared between the two stocks.

How does Fortress Biotech compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Fortress Biotech (NASDAQ:FBIOP) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$46.18MN/AN/AN/AN/A
Fortress Biotech$68.47MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Fortress Biotech N/A N/A N/A

In the previous week, Biofrontera and Biofrontera both had 1 articles in the media. Fortress Biotech's average media sentiment score of 0.55 beat Biofrontera's score of 0.00 indicating that Fortress Biotech is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Biofrontera
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Fortress Biotech
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Fortress Biotech beats Biofrontera on 2 of the 2 factors compared between the two stocks.

How does Fortress Biotech compare to Cingulate?

Fortress Biotech (NASDAQ:FBIOP) and Cingulate (NASDAQ:CINGW) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fortress Biotech$68.47MN/AN/AN/AN/A
CingulateN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Fortress BiotechN/A N/A N/A
Cingulate N/A N/A N/A

In the previous week, Fortress Biotech had 1 more articles in the media than Cingulate. MarketBeat recorded 1 mentions for Fortress Biotech and 0 mentions for Cingulate. Fortress Biotech's average media sentiment score of 0.55 beat Cingulate's score of 0.00 indicating that Fortress Biotech is being referred to more favorably in the media.

Company Overall Sentiment
Fortress Biotech Positive
Cingulate Neutral

Summary

Fortress Biotech beats Cingulate on 3 of the 3 factors compared between the two stocks.

How does Fortress Biotech compare to Clever Leaves?

Clever Leaves (NASDAQ:CLVR) and Fortress Biotech (NASDAQ:FBIOP) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, analyst recommendations, institutional ownership and media sentiment.

6.9% of Clever Leaves shares are owned by institutional investors. 8.2% of Clever Leaves shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
Clever LeavesN/A N/A N/A
Fortress Biotech N/A N/A N/A

In the previous week, Fortress Biotech had 1 more articles in the media than Clever Leaves. MarketBeat recorded 1 mentions for Fortress Biotech and 0 mentions for Clever Leaves. Fortress Biotech's average media sentiment score of 0.55 beat Clever Leaves' score of 0.00 indicating that Fortress Biotech is being referred to more favorably in the news media.

Company Overall Sentiment
Clever Leaves Neutral
Fortress Biotech Positive

Fortress Biotech has higher revenue and earnings than Clever Leaves.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clever Leaves$17.42M0.00-$17.90M-$9.66N/A
Fortress Biotech$68.47MN/AN/AN/AN/A

Summary

Fortress Biotech beats Clever Leaves on 3 of the 5 factors compared between the two stocks.

How does Fortress Biotech compare to Comera Life Sciences?

Fortress Biotech (NASDAQ:FBIOP) and Comera Life Sciences (NASDAQ:CMRAW) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, media sentiment, analyst recommendations, earnings and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fortress Biotech$68.47MN/AN/AN/AN/A
Comera Life Sciences$1.00MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Fortress BiotechN/A N/A N/A
Comera Life Sciences N/A N/A N/A

In the previous week, Fortress Biotech had 1 more articles in the media than Comera Life Sciences. MarketBeat recorded 1 mentions for Fortress Biotech and 0 mentions for Comera Life Sciences. Fortress Biotech's average media sentiment score of 0.55 beat Comera Life Sciences' score of 0.00 indicating that Fortress Biotech is being referred to more favorably in the media.

Company Overall Sentiment
Fortress Biotech Positive
Comera Life Sciences Neutral

Summary

Fortress Biotech beats Comera Life Sciences on 3 of the 3 factors compared between the two stocks.

Get Fortress Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for FBIOP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FBIOP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FBIOP vs. The Competition

Export
MetricFortress BiotechPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$12.49B$7.25B$12.95B
Dividend Yield12.11%2.64%2.57%12.80%
P/E RatioN/A644.99210.2920.60
Price / SalesN/A753.54656.3793.45
Price / CashN/A15.0828.1334.74
Price / BookN/A10.5110.506.32
Net IncomeN/A$2.82B$3.49B$358.20M
7 Day Performance-3.79%1.69%0.59%1.12%
1 Month Performance-2.85%0.24%-1.74%-2.39%
1 Year Performance97.33%3.95%18.13%5.35%

Fortress Biotech Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FBIOP
Fortress Biotech
N/A$17.75
-0.8%		N/A+97.3%$0.00$68.47MN/A170
SXTPW
60 Degrees Pharmaceuticals
N/A$0.04
+1.7%		N/A-22.0%$0.00$1.11MN/A2
BFRIW
Biofrontera
N/A$0.02
-0.5%		N/A-80.7%$0.00$46.18MN/A70
CINGW
Cingulate
N/A$0.01
+8.2%		N/A-87.9%$0.00N/AN/A20
CLVR
Clever Leaves
N/A$0.00
flat		N/A-50.0%$0.00$17.42MN/A560

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:FBIOP) was last updated on 9/20/2026 by MarketBeat.com Staff.
From Our Partners
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...
Behind the Markets | Sponsoredtc pixel
A “bloodbath” Is Coming
Reports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...
TradeSmith | Sponsoredtc pixel
Elon Musk to Trigger Next AI Wave on November 11th?
Jeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...
Brownstone Research | Sponsoredtc pixel
No Wallstreet. No Advisor. No Problem.
Savings accounts pay just 0.58 percent interest. Andy Howard, co-founder of Meridian Capital, says liquidity p...
Awesomely | Sponsoredtc pixel
The end of AI data centers coming?
Marc Chaikin's Power Gauge system flagged Micron before it soared 970 percent, Celestica before a 6,600 percen...
Chaikin Analytics | Sponsoredtc pixel
Gold majors have a big problem
Newmont spent 15 billion dollars acquiring Newcrest in 2023, the largest deal in gold mining history. Yet prod...
Golden Portfolio | Sponsoredtc pixel
The hidden costs of a hands-off retirement account
Contributing to your 401(k) consistently is good financial behavior - but contributing and optimizing are two ...
SmartAsset | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel